106 related articles for article (PubMed ID: 30776504)
21. WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.
Pellerito O; Notaro A; Sabella S; De Blasio A; Vento R; Calvaruso G; Giuliano M
Apoptosis; 2014 Jun; 19(6):1029-42. PubMed ID: 24696378
[TBL] [Abstract][Full Text] [Related]
22. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
[TBL] [Abstract][Full Text] [Related]
23. WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells.
Wasik AM; Almestrand S; Wang X; Hultenby K; Dackland ÅL; Andersson P; Kimby E; Christensson B; Sander B
Cell Death Dis; 2011 Nov; 2(11):e225. PubMed ID: 22048168
[TBL] [Abstract][Full Text] [Related]
24. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
25. The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.
Pellerito O; Calvaruso G; Portanova P; De Blasio A; Santulli A; Vento R; Tesoriere G; Giuliano M
Mol Pharmacol; 2010 May; 77(5):854-63. PubMed ID: 20159939
[TBL] [Abstract][Full Text] [Related]
26. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture.
Freitas HR; Isaac AR; Silva TM; Diniz GOF; Dos Santos Dabdab Y; Bockmann EC; Guimarães MZP; da Costa Calaza K; de Mello FG; Ventura ALM; de Melo Reis RA; França GR
Mol Neurobiol; 2019 Sep; 56(9):6472-6486. PubMed ID: 30838518
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
Gustafsson K; Christensson B; Sander B; Flygare J
Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
[TBL] [Abstract][Full Text] [Related]
29. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
30. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
[TBL] [Abstract][Full Text] [Related]
31. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis.
Petrella C; Agostini S; Alema' GS; Casolini P; Carpino F; Giuli C; Improta G; Linari G; Petrozza V; Broccardo M
Neurogastroenterol Motil; 2010 Nov; 22(11):1248-56, e323. PubMed ID: 20659297
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2.
Zhang G; Bi H; Gao J; Lu X; Zheng Y
Cell Biochem Funct; 2016 Jul; 34(5):351-8. PubMed ID: 27309350
[TBL] [Abstract][Full Text] [Related]
35. The endocannabinoid receptors CB1 and CB2 affect the regenerative potential of adipose tissue MSCs.
Ruhl T; Karthaus N; Kim BS; Beier JP
Exp Cell Res; 2020 Apr; 389(1):111881. PubMed ID: 32006556
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
[TBL] [Abstract][Full Text] [Related]
37. Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells.
Xian XS; Park H; Cho YK; Lee IS; Kim SW; Choi MG; Chung IS; Han KH; Park JM
J Cell Biochem; 2010 May; 110(2):321-32. PubMed ID: 20336665
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.
Selvi E; Lorenzini S; Garcia-Gonzalez E; Maggio R; Lazzerini PE; Capecchi PL; Balistreri E; Spreafico A; Niccolini S; Pompella G; Natale MR; Guideri F; Laghi Pasini F; Galeazzi M; Marcolongo R
Clin Exp Rheumatol; 2008; 26(4):574-81. PubMed ID: 18799087
[TBL] [Abstract][Full Text] [Related]
39. Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2.
Fonseca BM; Fernandes R; Almada M; Santos M; Carvalho F; Teixeira NA; Correia-da-Silva G
Toxicology; 2019 Feb; 413():40-47. PubMed ID: 30502353
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
Feng YJ; Li YY; Lin XH; Li K; Cao MH
World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
